Eun-Rim Kang

Eun-Rim Kang

Auto-generated profile, based on publicly available information

Eun-Rim Kang

Clinical Research Institute/Molecular Diagnosis Center

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2021 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
PDF file
KRKyoung Ho Roh
Kyoung Ho Roh
YKYu Kyung Kim
Yu Kyung Kim
SKShin-Woo Kim
Shin-Woo Kim
EKEun-Rim Kang
Eun-Rim Kang
YYYong-Jin Yang
Yong-Jin Yang
NSNackmoon Sung
Nackmoon Sung
The detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in upper and lower respiratory specimens and coinfection with other respiratory pathogens in patients with coronavirus disease 2019 (COVID-19) was investigated. Study subjects (N=342) were retrospectively enrolled after being confirmed as SARS-CoV-2 positive, and their nasopharyngeal swab (NPS), oropharyngeal swab (OPS), and sputum specimens were restored for SARS-CoV-2 retesting and respiratory pathogen detection. The majority of the subjects (96.5, N=330) were confirmed as SARS-CoV-2 positive using NPS/OPS specimens. Among the COVID-19 patients (N=342), 7.9 (N=27) and 0.9 (N=3) were coinfected with respiratory viruses and Mycoplasma pneumoniae, respectively, yielding an 8.8 (N=30) overall respiratory pathogen coinfection rate. Of the respiratory virus coinfection cases (N=27), 92.6 (N=25) were coinfected with a single respiratory virus and 7.4 (N=2) with two viruses (metapneumovirus/adenovirus and rhinovirus/bocavirus). No triple coinfections of other respiratory viruses or bacteria with SARS-CoV-2 were detected. Respiratory viruses coinfected in the patients with COVID-19 were as follows: rhinovirus (N=7, 2.1), respiratory syncytial virus A and B (N=6, 1.8), non-SARS-CoV-2 coronaviruses (229E, NL63, and OC43, N=5, 1.5), metapneumovirus (N=4, 1.2), influenza A (N=3, 0.9), adenovirus (N=3, 0.9), and bocavirus (N=1, 0.3). In conclusion, the diagnostic value of utilizing NPS/OPS specimens is excellent, and, as the first report in Korea, coinfection with respiratory pathogens was detected at a rate of 8.8 in patients with COVID-19.

19 December 2020 in medRxiv
Verified
Preprint
Open access
PDF file
KRKyoung Ho Roh
Kyoung Ho Roh
YKYu Kyung Kim
Yu Kyung Kim
SKShin-Woo Kim
Shin-Woo Kim
EKEun-Rim Kang
Eun-Rim Kang
YYYong-Jin Yang
Yong-Jin Yang
NSNackmoon Sung
Nackmoon Sung
Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in upper and lower respiratory specimens and coinfection with other respiratory pathogens in patients with coronavirus disease 2019 (COVID-19) were investigated. From the study subjects (N = 258) retrospectively enrolled when confirmed as SARS-CoV-2 positive, nasopharyngeal (NPS), oropharyngeal swabs (OPS), and sputum specimens were restored for retesting SARS-CoV-2 and detecting respiratory pathogens. Majority of the study subjects (95.7%, N = 247) were confirmed as SARS-CoV-2 positive using NPS/OPS specimens, suggesting that the upper respiratory specimen is most valuable in detecting SARS-CoV-2. Coinfection rates in COVID-19 patients (N = 258) with respiratory pathogens were 9.7% (N = 25); 8.5% (N = 22) respiratory viruses and 1.2% (N = 3) Mycoplasma pneumoniae , an atypical bacterium. Of the respiratory virus coinfection cases (N = 22), 20 (90.9%) were co-infected with a single respiratory virus and 2 (0.8%) (metapneumovirus/adenovirus and rhinovirus/bocavirus 1/2/3/4) with two viruses. Respiratory viruses in single viral coinfection cases with SARS-CoV-2 were as follows: non-SARS-CoV-2 coronaviruses (229E, NL63, and OC43, N = 5, 1.9%), rhinovirus (N = 4, 1.6%), metapneumovirus (N = 3, 1.2%), influenza A (N = 3, 1.2%), respiratory syncytial virus A and B (N = 3, 1.2%), and adenovirus (N = 2, 0.8%). No mixed coinfections with respiratory viruses and M. pneumonia e were found. In conclusion, the diagnostic value of utilizing NPS/OPS specimen is excellent, and, as the first report in Korea, coinfection with respiratory pathogens were detected at a rate of 9.7% in patients with COVID-19.